Skip to content

Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients

Topical Application of Silver Nanoparticles Reduced Oral Pathogens in Mechanically Ventilated Patients: A Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02761525
Enrollment
50
Registered
2016-05-04
Start date
2014-10-31
Completion date
2015-07-31
Last updated
2016-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

silver nanoparticles antimicrobial activity

Brief summary

The purpose of this study is to determine whether oral topic silver nanoparticles are effective to reduce potential pathogen microbial loads in mechanical ventilation patients.

Detailed description

All patients were performed with oral hygiene as recommended by the clinical practice guidelines for the prevention, diagnosis and treatment of pneumonia associated with mechanical ventilation. After that, placed the treatment of an innocuous gel compound with 12ppm of silver nanoparticles or gel alone according to randomization. Then obtain and plant samples taken before the treatment 6 hours after. Comparing the results of the baseline sample with the final.

Interventions

Allocation was randomized. Evaluate the effectiveness of silver nanoparticles incorporated into an innocuous gel and dished in oral mucosa surface to then compare with another innocuous gel without silver nanoparticles to reduce microbial colony forming units of pathogenic potential.

OTHERplacebo

Compare with another innocuous gel without silver nanoparticles to reduce microbial colony forming units of pathogenic potential using the same procedure to dished the gel.

Sponsors

Universidad Autonoma de San Luis Potosí
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
15 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with at least 24 hrs application endotracheal tube and ventilator support were nasogastric tube ,in the ICU of Hospital Central Dr. Ignacio Morones Prieto 2. Patients with at least 24 hours of ICU admission. 3. Sedo - analgesia patients in a coma or induced coma. 4. Over 15 years old 5. Informed consent signed by a family member or legal guardian of the patient.

Exclusion criteria

1. The patient is not taking part in another study that cause conflict with the present test. 2. Patients who develop bronchiectasis , severe or massive hemoptysis , cystic fibrosis. 3. Patients with known sensitivity to silver. 4. Patients who had reported difficult intubation in the record. 5. Patients whose physical condition does not allow the completion of the oral examination, proper sampling or application of gel. 6. Pregnant women 7. Patients with oral mucositis

Design outcomes

Primary

MeasureTime frameDescription
Compare Colony Forming Units after the intervention. Unique dosis.Comparison of microbial colony forming units at 6 hr of treatment with gel applicationBefore oral hygiene in the intubated patient, it was taken with sterile swab, a saliva sample which was sown in dextrose Sabouraud agar and tryptone soya agar. 6 hours later, placement of the experimental gel, retook saliva sample with a sterile swab and they seeded in the same agars . Colony forming units were counted before and after the intervention using semi-automated colony counter .

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026